Abstract
SARS-CoV-2 is a zoonotic virus that has caused a pandemic of severe respiratory disease-COVID-19-within several months of its initial identification. Comparable to the first SARS-CoV, this novel coronavirus's surface Spike (S) glycoprotein mediates cell entry via the human ACE-2 receptor, and, thus, is the principal target for the development of vaccines and immunotherapeutics. Molecular information on the SARS-CoV-2 S glycoprotein remains limited. Here we report the crystal structure of the SARS-CoV-2 S receptor-binding-domain (RBD) at a the highest resolution to date, of 1.95 Å. We identified a set of SARS-reactive monoclonal antibodies with cross-reactivity to SARS-CoV-2 RBD and other betacoronavirus S glycoproteins. One of these antibodies, CR3022, was previously shown to synergize with antibodies that target the ACE-2 binding site on the SARS-CoV RBD and reduce viral escape capacity. We determined the structure of CR3022, in complex with the SARS-CoV-2 RBD, and defined a broadly reactive epitope that is highly conserved across betacoronaviruses. This epitope is inaccessible in the "closed" prefusion S structure, but is accessible in "open" conformations. This first-ever resolution of a human antibody in complex with SARS-C...Continue Reading
Citations
May 19, 2020·Nature·Dora PintoDavide Corti
May 10, 2020·Viruses·Katharine H D CrawfordJesse D Bloom
Aug 6, 2020·Nature Structural & Molecular Biology·Matthew McCallumDavid Veesler
Nov 8, 2020·Science·Kevin W NgGeorge Kassiotis
Jan 12, 2021·JCI Insight·Caroline AtyeoGalit Alter
Nov 14, 2020·International Immunopharmacology·V Kumar
Apr 11, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Saraiya TanmayKonstantinos Poulas
Apr 21, 2021·NPJ Vaccines·Kirill V KalninDanilo Casimiro
Jun 24, 2021·Journal of Cellular Biochemistry·Abdolreza EsmaeilzadehMajid Ahmadi
Jul 29, 2021·Science Translational Medicine·Joseph R FrancicaRobert A Seder
Oct 17, 2020·ACS Pharmacology & Translational Science·Dhanusha A Nalawansha, Kusal T G Samarasinghe
Jun 17, 2020·The Journal of Physical Chemistry Letters·Cécilia HognonAntonio Monari
Oct 31, 2021·Nature Immunology·Vincent DussuptShelly J Krebs